| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $94.2B | $88.8B | $21.4B | $94.9B | $93.8B | $82.6B | $20.7B | $20.4B |
| Cost of Revenue | $30.3B | $27.5B | $26.6B | $31.1B | $29.9B | $28.4B | $27.6B | — |
| Gross Profit | $63.9B | $61.4B | $14.6B | $63.9B | $63.9B | $54.2B | $13.6B | $13.4B |
| R&D Expense | $0.1B | $1.8B | $0.5B | — | — | — | — | — |
| SG&A Expense | $23.7B | $22.9B | $21.5B | $24.8B | $24.7B | $22.1B | $22.2B | $22.5B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $26.8B | $14.1B | $4.0B | $17.9B | $20.9B | $14.7B | $4.0B | $3.0B |
| EPS (Basic) | $11.13 | $5.84 | $1.68 | $6.83 | $7.93 | $5.59 | $1.52 | $1.14 |
| EPS (Diluted) | $11.03 | $5.79 | $1.67 | $6.73 | $7.81 | $5.51 | $1.50 | $1.12 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $199.2B | $180.1B | $167.6B | $187.4B | $182.0B | $174.9B | $157.7B | $153.0B |
| Current Assets | $55.6B | $55.9B | $53.5B | $55.3B | $61.0B | $51.2B | $45.3B | $46.0B |
| Cash & Equivalents | $19.7B | $24.1B | $21.9B | $14.1B | $14.5B | $14.0B | $17.3B | $18.1B |
| Total Liabilities | $117.7B | $108.6B | $98.8B | $110.6B | $108.0B | $111.6B | $98.3B | $93.2B |
| Current Liabilities | $54.1B | $50.3B | $46.3B | $55.8B | $45.2B | $42.5B | $36.0B | $31.2B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $24.5B | $24.3B | $22.8B | $21.2B | $23.4B | $23.5B | $23.4B | $22.2B |
| Investing Cash Flow | $-23.6B | $-18.6B | $0.9B | $-12.4B | $-8.7B | $-20.8B | $-6.2B | $-3.2B |
| Capital Expenditures | $4.8B | $4.4B | $4.5B | $4.0B | $3.7B | $3.3B | $3.5B | $3.7B |
| Financing Cash Flow | $-5.5B | $-3.1B | $-15.8B | $-8.9B | $-14.0B | $-6.1B | $-18.0B | $-18.5B |